Skip to content

Surgical Management of Multiple Mucoepidermoid Carcinoma and Adenocarcinoma

Surgical Management of Multiple Mucoepidermoid Carcinoma and Adenocarcinoma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03988959
Enrollment
7
Registered
2019-06-18
Start date
2019-01-01
Completion date
2019-06-01
Last updated
2019-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenocarcinoma; Mucoepidermoid Carcinoma

Keywords

salivary gland tumor

Brief summary

A case series of patient having mucoepidermoid carcinoma, had standard treatment protocol and surgeries and followup was performed and the patient postoperative quality of life and recurrent rate was recorded

Detailed description

This case series presents mucoepidermoid carcinoma. Palatal mass was resected with safety margin then immediate opturator inserted; superficial parotidectomy was also done for parotid lesion sparing facial nerve. Post-operative radiotherapy was recommended by pathologist due to evident perineural spread. The patient is tumor free after one year follow-up. Clinical reports about synchronous multiple salivary tumors are very rare, consequently there is little known about its management and clinical presentation. Presence of one or more risk factor should favor expectation of multiple tumors and mandate examination of all salivary tissues. Each tumor should be diagnosed and treated separately according to its nature and extension.

Interventions

PROCEDUREresection of mucoeidermoid carcinoma

Surgical resection parotid with preservation of facial nerve

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

No masking was done since its a case series

Intervention model description

a case series was performed on 7 patients having mucoepidermoid carcinoma

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients suffering from salivary gland tumor

Exclusion criteria

* healthy patients with no tumors

Design outcomes

Primary

MeasureTime frameDescription
Quality of life6 monthsin grades the quality of life of patients is assessed by visual analogue scale in a scale from 1-10. higher values indicates better quality of life

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026